SimaJehaMD
Pediatric Hematology & Oncology • Memphis, TNProfessor, Pediatrics, University of Tennessee Health Science Center College of Medicine
Dr. Jeha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1987 - 1992
American University of Beirut Faculty of MedicineClass of 1983
Certifications & Licensure
TN State Medical License 2003 - 2025
TX State Medical License 1992 - 2009
CO State Medical License 1990 - 1995
Clinical Trials
- A Study of Children With Refractory or Relapsed ALL Start of enrollment: 1997 Feb 01
- Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia Start of enrollment: 2007 Oct 29
- Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma Start of enrollment: 2006 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia.Zhenhua Li, Huanbin Zhao, Wenjian Yang, Maud Maillard, Satoshi Yoshimura
Nature Communications. 2025-01-29 - 1 citationsOutcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies.Katelyn Purvis, Yinmei Zhou, Seth E Karol, Jeffrey E Rubnitz, Raul C Ribeiro
Blood. 2025-01-09 - Measuring Stigma in Pediatric Oncology: A Cross-Sectional Analysis of Three Global Sites.Lara E Counts, Robin S Tanner, Yichen Chen, Meenakshi Devidas, Gia Ferrara
JCO Global Oncology. 2025-01-01
Journal Articles
- Serum ALT Elevations in Survivors of Childhood Cancer. A Report from the St. Jude Lifetime Cohort StudyMatthew J Krasin, Sima Jeha, Daniel M Green, Melissa M Hudson, Wayne L Furman, Michael W Bishop, Hepatology
Abstracts/Posters
- The Genomic Landscape of Childhood Acute Lymphoblastic LeukemiaSima Jeha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 ...Sima Jeha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Traumatic and Bloody Lumbar Puncture at Diagnosis in Children with Acute Lymphoblastic Leukemia: A St. Jude Total XV and Total Xvi Cohort Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: R...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Join Marlo Thomas During "Yalla, Together for St. Jude" on Feb. 4 at 7 p.m. ET for a Founder's Day Celebration of St. Jude Children's Research HospitalFebruary 3rd, 2021
Join Marlo Thomas During "Yalla, Together for St. Jude" on Feb. 4 at 7 p.m. ET for a Founder's Day Celebration of St. Jude Children's Research HospitalFebruary 3rd, 2021
St. Jude Children’s Research Hospital Clinical Trial Results Reduce Rate of Relapse for Children with Acute Lymphoblastic Leukemia (ALL)October 29th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
